Q4 2014 13F Holders as of 31 Dec 2014
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
294,683,714
-
Total 13F shares
-
49,165,950
-
Share change
-
+194,996
-
Total reported value
-
$747,418,239
-
Put/Call ratio
-
2.9%
-
Price per share
-
$15.21
-
Number of holders
-
157
-
Value change
-
+$7,297,640
-
Number of buys
-
66
-
Number of sells
-
69
Institutional Holders of SANGAMO THERAPEUTICS, INC - Common Stock (SGMO) as of Q4 2014
As of 31 Dec 2014,
SANGAMO THERAPEUTICS, INC - Common Stock (SGMO) was held by
157 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
49,165,950 shares.
The largest 10 holders included
FMR LLC, WASATCH ADVISORS INC, BlackRock Fund Advisors, State Street Corp, ADAGE CAPITAL PARTNERS GP LLC, VANGUARD GROUP INC, BlackRock Institutional Trust Company, N.A., FRONTIER CAPITAL MANAGEMENT CO LLC, JENNISON ASSOCIATES LLC, and Bank of New York Mellon Corp.
This page lists
157
institutional shareholders reporting positions in this security
for the Q4 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.